【即刻报名，一站式精准出海】2024亚太健康与生命科学峰会报名开启：深度聚焦产业全景，抢占亚太市场新机遇！

人在书途不孤独

亚太健康与生命科学领袖的巅峰聚会

人在书途不孤独

跨行业协作推动健康与生命科学创新

人在书途不孤独

促进合作、创新与市场准入的理想平台

聆听来自公共与私营部门的顶级专家分享他们在亚洲健康与生命科学领域的最新经验与观点。

与亚太地区健康与生命科学行业的政策制定者、发展伙伴和高管建立有价值的联系。

利用非正式交流的机会，寻找行业内新的潜在合作伙伴，拓展业务合作空间。

【Development partner/ Government Agency/ Academic Institution】

• Deepali KHANNA, Vice President, Asia, The Rockefeller Foundation

• Shyam BISHEN Head, Centre for Health and Healthcare; Member of the Executive Committee, World Economic Forum

• Yoshihiro KAWAI, Chairman of Global Asia Insurance Partnership (GAIP); Chair, OECD lPPC & Senior Advisor to the Commissioner JFSA

• Paul HULEATT, Counsellor (Health), Australian High Commission, Singapore; Regional Advisor - Indo-Pacific Regulatory Strengthening Program (RSP); Australian Therapeutic Goods Administration (TGA)

• Ministry of Health  Indonesia 

• Joji SUGAWARA, Vice President, Health and Global Policy Institute (HGPI)

• Vera SIESJÖ, Senior One Health Scientist, Asia Infrastructure Investment Bank (AIIB)

• Jiadi YU, Chief Investment Officer, International Finance Corporation (IFC)

• Carrie LIU, Lead, Health and Healthcare, World Economic Forum

• Dawn CHAN, CEO, Centre for Impact and Practices (CIIP); Managing Director, Investments, Temasek Trust Capital

• Holly WHEELER, Principal, Office of Strategic Affairs, Reaching the Last Mile, UAE President Office

• Giles NEWMARCH, Senior Investment Officer, lFC-International Finance Corporation (World Bank)

• Wenfeng GONG, Senior Strategy Officer, China Office, Bill & Melinda Gates Foundation

• Ryan MACFARLANE, Vice President, Access Partnership

• Ritesh Thakkar, Senior Advisor and Head of Asia Pacific, Convergence Blended Finance

• John ENG, Vice President Healthcare, Singapore Economic Development Board (EDB)

• Hwee Ching ANG, Deputy Chief Executive OfficerExperimental Drug Development Centre (EDDC)

• Yuan Lu HO, Co-lead, ASEAN Diagnostics Initiative, Vice President, Outreach & Talent Development, Diagnostics Development Hub

• Lin SHI, Policy Director, China Office, the Pharmaceutical Research and Manufacturers of America (PhRMA)

• Chen Ee LEE, Group Director, Innovation & Transformation, SingHealth

• Jonas KARLSTRÖM, Associate Professor, Core Lead, Innovation in Global Health, SingHealth Duke-NUS Global Health Institute

• Renzo R. GUINTO, Associate Professor, Global and Planetary Health, SingHealth Duke-NUS Global Health Institute, Duke-NUS Medical School, Singapore

• Stéphanie J. BATOT, Deputy Director, Strategic Partnerships, SingHealth Duke-NUS Global Health Institute

• Kelvin TAN, Head of Programme (Minor in Applied Ageing Studies), Singapore University of Social Sciences (SUSS)

• Ankur MUTREJA, Director of Strategy, Partnerships and Communications, PATH 

【Industry and Investment Leaders】

• Dion Warren, I-SEA MCO Head, Takeda Pharmaceuticals

• Siyuan CHEN VP, General Manager of Bristol Myers Squibb for China & Asia Cluster

• Dale HUNTINGTON, Senior Director, Health Care Systems Policy, Johnson & Johnson

• Angeline CHIN, Director APAC Sustainability,  Johnson & Johnson

• Ye LI, Head of Corporate Affairs, Merck China

• Peng ZHONG, Director, Social Innovation, Bayer Foundation

• Pompy SRIDHAR, Director- India, MSD for Mothers

• Coco LIU, ESG and Sustainability Lead, Philips Greater China

• Jean-Gaetan Guillemaud, Vice President Corporate Affairs, Zuellig Pharma

• Karen WU, Regional Lead of APAC Supply Chain, Roche Singapore

• Biao CHENG, GM of Incubation, Microsoft Asia-Pacific Research & Development Group

• Subramanyam YADAVALLI, CEO, Apollo Hospitals

• Siddhartha BHATTACHARYA, Secretary General, Healthcare Federation of India (NATHEALTH)

• Janice JIN, President, GenScript Asia Pacific

• Jianguo YIN, Chairman, BioBAY

• Nathan TIRTANA, President Director, PT Etana Biotechnologies Indonesia

• Andrew WONG, General Manager of Shanghai Wotai Biotechnology Co., Ltd.

• Sean SHI, Director & CEO, Sino-Innovax Biotec Pte Ltd

• Christy MA, Chief Strategy Officer, SCG Cell Therapy

• Ramesh RAJENTHERAN, CEO & Founder, MiyaHealth

• Ben LI, Founder, Heals Healthcare

• Arjun Sarker, CEO, Dawn Medical Technologies

• Eugene HONG, Executive Director, Pharmaceuticals and Healthcare, DBS Bank

• Jin Hoe KOH, Executive Director, Head, Capital Markets, Global Sales and Origination, SGX Group

• Alessandro FALCONE, Head of Johnson & Johnson Innovation, JLABS Singapore

• Anupama PURANIK, Managing Director, Russell Reynolds Associates

• Faye ONG, Asia Head, Family Office and Philanthropic Advisory, Global Family Office, Citi Private Bank

• Jolene OOI, Senior Principal, Healthcare and Emerging Technology Investments, EDBI Pte Ltd

• May LO, Director, ABC Impact, Temasek Trust Asset Management

• Vijay KARWAL, Managing Director, CBC Group

• Kelly QIAO, Senior Principal, B Capital Group

• Mia HU, Investment Director, Boehringer Ingelheim Venture Fund Asia

• Stephen Ng, Managing Director; Head of Southeast Asia and South Asia; Chief Executive Officer of Singapore, CICC

• Luming DENG, Chief Executive Officer, Haitong International Securities

• Albert HUANG, Managing Director, YunFeng Capital

• Fong Ming KOH, Investment Principal, LYFE Capital

• Alva CHEN, Therapeutic Practice Leader, Healthcare, VMS Group

• Anne XIE, Executive Director, Yijing Capital

为期两天的峰会通过八个不同的话题，聚焦亚洲生命科学创新和产业全景和战略性市场机遇两大主题，汇集了来自亚洲近20个国家和地区的卫生系统领导人、国际组织代表、政策专家、学术领袖和生态系统合作伙伴。

了解更多信息，请访问：www.askhealthasia.com

新加坡经济发展局（Economic Development Board，简称 EDB）是隶属于贸易与工业部的政府机构，负责规划战略，旨在加强新加坡作为全球商业、创新和人才中心的地位。

我们的职责

我们的使命是为新加坡创造可持续的经济增长、繁荣的商业环境以及良好的工作岗位。

我们负责推动制造业和国际可交易服务业的投资以及产业发展。我们负责的产业范围占据新加坡年度国内生产总值的三分之一。除了促进投资外，我们也与已在新加坡落地的企业合作，协助其转型、提高生产力，同时也协助企业在新加坡拓展业务，创造新模式，开拓新市场，在相近或者突破性的领域内实现增长。

我们与企业紧密合作，为其提供信息，搭建伙伴关系，并且为企业在新加坡的投资提供政府优惠政策以及转型和增长的动议。此外，我们也与其他的新加坡政府机构协作，完善亲商的商业环境，并且积极推动人才发展，确保我们的产业能得到全球范围内具有竞争力的人才支持。